Načítá se...
Genetically modified mesenchymal stromal cells in cancer therapy
The cell therapy industry has grown rapidly over the past 3 decades, and multiple clinical trials have been performed to date covering a wide range of diseases. The most frequently used cell is mesenchymal stromal cells (MSCs), which have been used largely for their anti-inflammatory actions and in...
Uloženo v:
| Vydáno v: | Cytotherapy |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Elsevier
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5082580/ https://ncbi.nlm.nih.gov/pubmed/27745603 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jcyt.2016.09.003 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|